Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,965.00
Bid: 1,968.00
Ask: 1,970.00
Change: 7.00 (0.36%)
Spread: 2.00 (0.102%)
Open: 1,977.00
High: 1,980.00
Low: 1,957.00
Prev. Close: 1,958.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: UBS cuts DS Smith; Kepler likes Genus

Wed, 20th Dec 2023 09:25

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

----------

FTSE 100

----------

Goldman Sachs cuts Reckitt Benckiser price target to 5,900 (6,680) pence - 'neutral'

----------

Bank of America raises Rolls-Royce price target to 420 (400) pence - 'buy'

----------

Stifel cuts Land Securities price target to 750 (780) pence - 'buy'

----------

Stifel raises Segro price target to 875 (775) pence - 'hold'

----------

Jefferies cuts Hikma Pharmaceuticals price target to 1,880 (1,940) pence - 'hold'

----------

UBS cuts DS Smith to 'neutral' (buy) - price target 332 (361) pence

----------

JPMorgan cuts Burberry price target to 1,500 (1,650) pence - 'neutral'

----------

Jefferies cuts Burberry price target to 1,600 (1,800) pence - 'hold'

----------

Barclays raises Centrica price target to 205 (200) pence - 'overweight'

----------

Berenberg raises BAE Systems price target to 1,220 (1,170) pence - 'buy'

----------

RBC cuts HSBC price target to 750 (775) pence - 'sector perform'

----------

RBC raises Barclays price target to 230 (205) pence - 'outperform'

----------

RBC raises Lloyds price target to 70 (65) pence - 'outperform'

----------

RBC raises NatWest price target to 320 (290) pence - 'sector perform'

----------

FTSE 250

----------

RBC cuts Virgin Money UK price target to 200 (210) pence - 'sector perform'

----------

Jefferies raises Travis Perkins price target to 858 (813) pence - 'hold'

----------

Stifel raises Tritax Big Box REIT price target to 165 (140) pence - 'hold'

----------

Stifel raises LondonMetric Property price target to 200 (180) pence - 'hold'

----------

Stifel cuts Great Portland Estates price target to 490 (575) pence - 'buy'

----------

Stifel cuts British Land price target to 450 (500) pence - 'buy'

----------

Kepler Cheuvreux reinitiates Genus with 'buy' - price target 2,404 pence

----------

SMALL CAP

----------

RBC cuts Metro Bank price target to 45 (50) pence - 'sector perform'

----------

RBC raises Adriatic Metals price target to 350 (335) pence - 'outperform'

----------

Stifel raises Triple Point Energy Transition price target to 65 (55) pence - 'hold'

----------

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
21 Jun 2021 14:51

UPDATE 1-U.S. Supreme Court denies Amarin's bid to revive Vascepa drug patents

(Adds background to case, paragraphs 4-10)By Blake BrittainWASHINGTON, June 21 (Reuters) - The U.S. Supreme Court on Monday rejected a bid by an Amarin Corp PLC subsidiary to revive patents on its heart drug Vascepa in a legal battle against gener...

Read more
21 Jun 2021 14:31

U.S. Supreme Court denies Amarin's bid to revive Vascepa drug patents

WASHINGTON, June 21 (Reuters) - The U.S. Supreme Court on Monday rejected a bid by an Amarin Corp PLC subsidiary to revive patents on its heart drug Vascepa in a legal battle against generic drugmakers Hikma Pharmaceuticals PLC and Dr. Reddy's La...

Read more
8 Jun 2021 13:54

Tuesday broker round-up

(Sharecast News) - tinyBuild: Berenberg reiterates buy with a target price of 295p.

Read more
6 May 2021 09:46

BROKER RATINGS: Exane BNP downgrades three property companies

BROKER RATINGS: Exane BNP downgrades three property companies

Read more
30 Apr 2021 17:01

LONDON MARKET CLOSE: Stocks close out impressive April to end higher

LONDON MARKET CLOSE: Stocks close out impressive April to end higher

Read more
30 Apr 2021 08:58

TOP NEWS: Hikma Pharma confident after promising start to year

TOP NEWS: Hikma Pharma confident after promising start to year

Read more
30 Apr 2021 07:57

LONDON MARKET PRE-OPEN: Barclays, AstraZeneca post sharp profit rises

LONDON MARKET PRE-OPEN: Barclays, AstraZeneca post sharp profit rises

Read more
30 Apr 2021 07:38

Hikma predicts generics revenue at top of guidance

(Sharecast News) - Hikma Pharmaceutical said it made a good start to 2021 and that annual revenue from generic treatments would be at the top of guidance.

Read more
23 Apr 2021 16:01

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
21 Apr 2021 12:08

LONDON MARKET MIDDAY: Stocks recover modestly; Netflix misses targets

LONDON MARKET MIDDAY: Stocks recover modestly; Netflix misses targets

Read more
21 Apr 2021 10:06

Hikma resumes asthma drug launch, Vectura pays special dividend

Hikma resumes asthma drug launch, Vectura pays special dividend

Read more
21 Apr 2021 09:01

LONDON MARKET OPEN: Stocks rise; Just Eat sinks on Germany competition

LONDON MARKET OPEN: Stocks rise; Just Eat sinks on Germany competition

Read more
21 Apr 2021 07:52

LONDON MARKET PRE-OPEN: Anto holds outlook, BHP cuts coal guidance

LONDON MARKET PRE-OPEN: Anto holds outlook, BHP cuts coal guidance

Read more
21 Apr 2021 07:30

Hikma resumes US launch of 'Advair Diskus' generic

(Sharecast News) - Hikma Pharmaceuticals has resumed the launch of its generic version of GlaxoSmithKline's 'Advair Diskus' in the United States, it announced on Wednesday, following Food and Drug Administration (FDA) approval of an amendment it submitted to its Abbreviated New Drug Application in January.

Read more
19 Apr 2021 16:02

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.